iSpecimen (NASDAQ:ISPC – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.09, Zacks reports. iSpecimen had a negative net margin of 124.84% and a negative return on equity of 105.25%. The business had revenue of $2.86 million for the quarter.
iSpecimen Price Performance
Shares of ISPC stock remained flat at $0.25 during trading hours on Wednesday. The company’s stock had a trading volume of 361,413 shares, compared to its average volume of 2,226,001. iSpecimen has a 52-week low of $0.20 and a 52-week high of $1.52. The company’s fifty day moving average is $0.32 and its 200 day moving average is $0.34. The firm has a market capitalization of $3.27 million, a P/E ratio of -0.20 and a beta of 1.60.
iSpecimen Company Profile
Featured Articles
- Five stocks we like better than iSpecimen
- What is a Low P/E Ratio and What Does it Tell Investors?
- What Are Bonds? A High-Level Overview
- What Are Dividend Contenders? Investing in Dividend Contenders
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- 10 Best Airline Stocks to Buy
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.